- Home
- RVPHW vs ARBEW Comparison
RVPHW vs ARBEW Comparison
Compare RVPHW & ARBEW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RVPHW
- ARBEW
- Stock Information
- Founded
- RVPHW 2018
- ARBEW 2015
- Country
- RVPHW United States
- ARBEW Israel
- Employees
- RVPHW 14
- ARBEW 144
- Industry
- RVPHW Biotechnology: Pharmaceutical Preparations
- ARBEW EDP Services
- Sector
- RVPHW Health Care
- ARBEW Technology
- Exchange
- RVPHW Nasdaq
- ARBEW Nasdaq
- Market Cap
- RVPHW N/A
- ARBEW N/A
- IPO Year
- RVPHW N/A
- ARBEW N/A
- Fundamental
- Price
- RVPHW $0.04
- ARBEW $0.22
- Analyst Decision
- RVPHW
- ARBEW
- Analyst Count
- RVPHW 0
- ARBEW 0
- Target Price
- RVPHW N/A
- ARBEW N/A
- AVG Volume (30 Days)
- RVPHW 22.4K
- ARBEW 32.4K
- Earning Date
- RVPHW 03-14-2025
- ARBEW 03-05-2025
- Dividend Yield
- RVPHW N/A
- ARBEW N/A
- EPS Growth
- RVPHW N/A
- ARBEW N/A
- EPS
- RVPHW N/A
- ARBEW N/A
- Revenue
- RVPHW N/A
- ARBEW $768,000.00
- Revenue This Year
- RVPHW N/A
- ARBEW N/A
- Revenue Next Year
- RVPHW N/A
- ARBEW N/A
- P/E Ratio
- RVPHW N/A
- ARBEW N/A
- Revenue Growth
- RVPHW N/A
- ARBEW N/A
- 52 Week Low
- RVPHW $0.13
- ARBEW $0.13
- 52 Week High
- RVPHW $0.15
- ARBEW $1.25
- Technical
- Relative Strength Index (RSI)
- RVPHW N/A
- ARBEW N/A
- Support Level
- RVPHW N/A
- ARBEW N/A
- Resistance Level
- RVPHW N/A
- ARBEW N/A
- Average True Range (ATR)
- RVPHW 0.00
- ARBEW 0.00
- MACD
- RVPHW 0.00
- ARBEW 0.00
- Stochastic Oscillator
- RVPHW 0.00
- ARBEW 0.00
About RVPHW Reviva Pharmaceuticals Holdings Inc.
Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease and Parkinson's disease psychosis and its other drug candidate is RP1208.
About ARBEW Arbe Robotics Ltd. Warrant
Arbe Robotics Ltd is a provider of 4D Imaging Radar solutions enabling driver-assist systems while paving the way for fully autonomous driving. It is a research and development company in the field of chips for Advanced radar systems, which are mainly intended to be used as Advanced Driver Assistance Systems (ADAS) adapted for autonomous vehicles as well as for non-automotive uses. Its geographical segments include Sweden, China, Germany, Hong Kong, USA, Israel, Switzerland, Italy, and others.